Neusoft Medical Systems: Innovator of global healthcare services to enhance global healthcare.
Neusoft Medical Systems Co., Ltd. (referred to as “Neusoft Medical”), established in 1998 and headquartered in Shenyang, Liaoning Province, China, operates under the philosophy of “Caring for you” and is committed to providing cutting-edge medical imaging solutions and services.
Neusoft combines digital and intelligent technologies with innovative medical imaging. The potential of “Intelligent Imaging” is explained to provide customers with intelligent, precise, efficient and secure products.
Neusoft Medical offers an extensive range of nearly a hundred digital medical diagnosis and treatment solutions, including CT, MRI, DSA, PET/CT, GXR, US, RT, and IVD. These solutions are designed to support the high-quality development of healthcare institutions while providing access to valuable medical resources and clinical practices.
Leveraging Neusoft Medical’s large-scale installed base and the vast data it generates, innovative imaging data services are provided through MDaaS. The intelligent platform and applications are agile, reliable, and deployable on demand, empowering participants in the healthcare industry, government agencies, research partners, and others, fostering an intelligent and interconnected imaging ecosystem.
By utilizing deep learning technology and proprietary core algorithms, the integration of medical imaging and artificial intelligence is advanced, creating a comprehensive intelligent solution from device to application. This approach streamlines and optimizes clinical diagnosis and treatment processes, aiming to reduce healthcare professionals’ workload and enhance the overall patient experience.
Global Presence
Neusoft Medical, rooted in China, is actively expanding its global presence with 12 branches established across the United States, Germany, Brazil, Peru, Colombia, Kenya, the United Arab Emirates, Thailand, South Korea, and Vietnam. The company serves more than 13,000 medical institutions in over 110 countries, boasting a historical installation base of over 47,000 units. Focusing on equipment services and enhancing customer experience, Neusoft Medical has set up more than 70 service teams, spare parts centers, and training centers worldwide, creating a responsive support network. Through remote services and a cloud platform, this network enables real-time monitoring of equipment, offering early warnings and online support, which aids in precise hospital equipment management and operations.
Innovative Technology
Through continuous independent research and development, Neusoft Medical Systems has led the way in industry advancements, having developed China’s first CT scanner, superconductive MRI, and digital radiography system. Over the past two decades, the company’s high-end products have achieved significant breakthroughs, including China’s first 512-slice CT, the industry-first Dual-energy 3.0T MRI, the world’s first railless dual rotation center 7-axis ceiling-mounted angiography system, and the world’s first 180ps grade fully digitized PET/CT.
Furthermore, Neusoft Medical has established research and development centers and teams in several locations, including Shenyang, Beijing, Shanghai, Guangzhou, Nanjing, Houston (USA), and Gyeonggi-do (South Korea). With nearly 800 research and development personnel, the company has obtained over 1,500 patents and patent applications, along with the registration of nearly 200 software copyrights.
Mutually Beneficial Cooperation
Neusoft Medical has consistently adhered to the principle of win-win cooperation. In addition to providing technical and clinical application training to end-users, the company has established global training centers that have hosted hundreds of sessions and academic exchanges. These initiatives have helped thousands of radiologists enhance their professional skills. Neusoft Medical has also organized numerous high-level international exchanges in medical imaging, contributing to the creation of a cross-border knowledge-sharing platform within the field.
Additionally, in 2024, Neusoft Medical received strategic investment from China General Technology (Group) Holding Co., Ltd., a key state-owned enterprise. This partnership marked a new stage of development, fostering mutual empowerment and collaborative growth. Together, both parties are accelerating the research and development of new technologies and products, striving to continuously enhance innovation capabilities and core competitiveness in high-end medical equipment.
Finally, Neusoft Medical remains committed to promoting the widespread use of large medical equipment, ensuring that high-quality medical products and services are accessible to all.
Related Posts
International Symposium Explores Advancements in Belt and Road Bio-Health Agriculture
Further Information
